Biota Pharmaceuticals, Inc. 4
4 · Biota Pharmaceuticals, Inc. · Filed Nov 3, 2015
Insider Transaction Report
Form 4
COLONNESE MARK P
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-11-02$2.02/sh+225,000$454,500→ 225,000 totalExercise: $2.02From: 2016-11-02Exp: 2025-11-02→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]This stock option vests in equal annual installments beginning on the first, second, and third anniversary of the date ratably.